Quick Answer
Insight Molecular Diagnostics Inc. reported Total Assets of $25.76 million for fiscal year 2025.
Insight Molecular Diagnostics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $25.76M | -26.6% |
| 2024 | $35.08M | -53.2% |
| 2023 | $74.89M | -25.2% |
| 2022 | $100.09M | -37.3% |
| 2021 | $159.56M | +187.9% |
| 2020 | $55.42M | +39.0% |
| 2019 | $39.86M | +318.8% |
| 2018 | $9.52M | -6.8% |
| 2017 | $10.22M | -29.3% |
| 2016 | $14.45M | +13.5% |
| 2015 | $12.73M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $43.94M | -37.4% | -13.0% |
| June 30, 2025 | $50.52M | -32.4% | -16.3% |
| March 31, 2025 | $60.36M | -15.0% | +72.1% |
| December 31, 2024 | $35.08M | -53.2% | -50.0% |
| September 30, 2024 | $70.22M | -13.9% | -6.0% |
| June 30, 2024 | $74.72M | -14.6% | +5.3% |
| March 31, 2024 | $70.97M | -14.3% | -5.2% |
| December 31, 2023 | $74.89M | -25.2% | -8.2% |
- Insight Molecular Diagnostics Inc. showed a decrease of -26.6% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, Insight Molecular Diagnostics Inc.’s total assets has grown by 102.3% (from $12.73 million to $25.76 million).
- The most recent figure is from Insight Molecular Diagnostics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: